Navigation Links
XYOTAX in Medical News

Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results

...operating expenses in 2008, by focusing resources on reaching $15 million in net Zevalin revenues, pursuing European marketing authorization (MAA) for xyotax (paclitaxel poliglumex, CT-2103), preparing for a potential U.S. marketing application (NDA) for pixantrone (BBR 2778) in 2009, and supporting the adv...

Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009

...tates and preparing the marketing applications for xyotax (paclitaxel poliglumex, CT-2103) and pixantrone (B... some phase III clinical trials for pixantrone and xyotax until planned regulatory filings and the completio...uct approvals. CTI expects to file for approval of xyotax in Europe in March. The Company will expand its co...

Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline

... O'Byrne, M.D., presented the phase III results of xyotax in first-line treatment of non-small cell lung can...." Dr. O'Byrne also presented data suggesting that xyotax may be particularly effective in women with pre-me...ate. Based on preclinical studies, it appears that xyotax is preferentially distributed to tumors due to the...

Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results

...ion of ZEVALIN, coupled with progress on advancing xyotax toward a first half 2008 marketing application sub... phase III clinical trials, PGT307 and PIX303, for xyotax and pixantrone (BBR 2778), respectively. Including...pared to currently marketed anthracyclines. About xyotax XYOTAX(TM) (paclitaxel poliglumex) is a biologica...

Multiple deaths forces cancer trial to be called off

...d in a big way with enrollment made at 170 medical centers globally last April, and had planned to study about 600 patients to prove the efficacy of xyotax in increasing the life span of patients with lung cancer using a regularly used chemotherapy agent coupled with a polymer which is supposed to help in...

Experimental Drug Reduces Tumor Size When Given With Radiation

... An experimental drug xyotax was successful in shrinking stomach and esophagus tumors in four out of 12 cancer patients, according to its maker Cell Therapeutics.// The other pati...
XYOTAX in Medical Technology

European Regulatory Agency Accepts Cell Therapeutics, Inc.'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review

... beginning of March. The validation of the MAA for xyotax initiates the marketing approval review process, w...of the MAA. In the STELLAR 4 trial, single-agent xyotax resulted in comparable survival to gemcitabine or ...tor support. In addition to improved tolerability, xyotax offered more convenient administration compared to...

Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)

... xyotax to be reviewed for PS2 first-line non-small cell l...LAR trials. In the STELLAR 4 trial, single-agent xyotax resulted in comparable survival to gemcitabine or ...tor support. In addition to improved tolerability, xyotax offered more convenient administration compared to...

Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill

...atment for lung cancer. Data collected from recent xyotax trials suggests that estrogen levels may alter the...they respond differently to treatment. Through our xyotax studies, we continue to explore ways to turn a neg...ate. Based on preclinical studies, it appears that xyotax is preferentially distributed to tumors due to the...

Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill

...atment for lung cancer. Data collected from recent xyotax trials suggests that estrogen levels may alter the...they respond differently to treatment. Through our xyotax studies, we continue to explore ways to turn a neg...ate. Based on preclinical studies, it appears that xyotax is preferentially distributed to tumors due to the...

XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer

...source utilization (MRU) and associated costs with xyotax (paclitaxel polyglumex) treatment compared to gemc... average treatment cost, excluding drug costs, for xyotax patients was nearly half the cost of treatment for...tional, randomized trial (STELLAR 4) that compared xyotax (n=191) to gemcitabine or vinorelbine (n=190) in p...
XYOTAX in Biological Technology

Veteran Drug Industry Executive to Become President of CTI

...ation for FDA approval in late 2008 or early 2009. xyotax is also being studied independently in a phase III... negotiate an exclusive license for pixantrone. If xyotax receives regulatory approval in the U.S. or Europe...ir intended uses, a determination by the EMEA that xyotax should not be approved for sale in Europe, other d...

Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008

...resources to the GOG212 trial, a clinical trial of xyotax in first-line maintenance ovarian cancer being per... in the second half of 2009. The clinical trial of xyotax in combination with carboplatin in women with pre-...for the Company is to focus resources on obtaining xyotax and pixantrone approval with existing or completin...

Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule

...he STELLAR 4 phase III clinical trial results, for xyotax as a single agent for first-line treatment of non-...al The STELLAR 4 phase III clinical trial tested xyotax versus either gemcitabine or vinorelbine for the p...ate. Based on preclinical studies, it appears that xyotax is preferentially distributed to tumors due to the...

Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer

... significantly shorter than post-menopausal women. xyotax (TM) (paclitaxel poliglumex) will be studied in co...tion (MAA) in Europe in the first half of 2008 for xyotax as a single agent for first-line treatment of NSCL... 225 patients will be randomized to receive either xyotax 175mg/m2 plus carboplatin (AUC6) or paclitaxel 225...
Other Tags
(Date:7/14/2014)... EnergyFirst, manufacturer of all-natural nutritional ... for its great products, thriving customer base, and ... its products as Jim’s Permalean Protein Powders and Jim’s ... EnergyFirst’s lineup of nutritional products. The Permalean brand will ... , Founded in 1999, Permalean’s products were designed to ...
(Date:7/14/2014)... Summer is the best season of the ... beach, swimming and other outdoor adventures. The promotional product experts ... and healthy all summer long. The promo product gurus at ... must-have custom imprinted products everyone must have on hand this ... sunblock. Sunscreen helps protect skin from harmful UV ...
(Date:7/14/2014)... New research and analysis from the national women's ... examines toxic ingredients in tampons, a product used by ... that may be found in the product’s absorptive materials, ... women’s health at risk. , According to WVE’s ... the potential impact of toxic chemical exposure from tampons ...
(Date:7/14/2014)... Cadeon Associates Inc. http://www.cadeon.com ... Money,” today announced that it has joined the ... helps partners resell, deploy, and develop solutions that ... TIBCO Software Inc. is a global leader in ... analytics, providing businesses the ability to capture the ...
(Date:7/13/2014)... 14, 2014 FORT LEE, N.J. – Authors ... modern approach to the science of tooth implants ... This book describes recent advances and techniques in the ... that benefit people who have lost all of their natural ... the first lower subperiosteal implant in 1940. It was ...
Breaking Medicine News(10 mins):Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 2Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 3Health News:Why These Three Summer Essentials from 4AllPromos Can Improve Summer 2Health News:New Patent Analysis Shows Toxic Risk From Tampons 2Health News:New Patent Analysis Shows Toxic Risk From Tampons 3Health News:New Patent Analysis Shows Toxic Risk From Tampons 4Health News:New Patent Analysis Shows Toxic Risk From Tampons 5Health News:Cadeon Associates Inc. Joins TIBCO Spotfire Partner Network 2Health News:Cadeon Associates Inc. Joins TIBCO Spotfire Partner Network 3Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 2Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 3Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 4
(Date:7/11/2014)... University, Sweden, have explored two different ways that ... leading to the formation of oxygen molecules in ... the scientific journal Nature Communications . , ... synthetic catalysts for water oxidation, which are key ... direct storage of solar energy in fuels like ...
(Date:7/11/2014)... mesenchymal stem cells can stimulate neurogenesis in the brain ... (AD) and improve tissue and function injury under the ... the therapeutic effect of adipose-derived stem cells (ADSCs) transplantation ... oxidative injury and neurogenesis in the brain of AD ... Life Sciences, Tsinghua University, China transplanted ADSCs into the ...
(Date:7/11/2014)... type 1 can inhibit voltage-gated calcium channel, ... release. However, some scholars demonstrated that cannabinoid ... influx and increase neurotransmitter release. Dr. Yi ... to Tongji Medical College, Huazhong University of ... voltage-clamp and calcium imaging in cultured trigeminal ...
Breaking Biology News(10 mins):Molecular snapshots of oxygen formation in photosynthesis 2
Other Contents